Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment
Irit Adini, … , Diane R. Bielenberg, Robert J. D’Amato
Irit Adini, … , Diane R. Bielenberg, Robert J. D’Amato
Published December 20, 2013
Citation Information: J Clin Invest. 2014;124(1):425-436. https://doi.org/10.1172/JCI69404.
View: Text | PDF
Research Article

Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment

  • Text
  • PDF
Abstract

Studies have established that pigmentation can provide strong, protective effects against certain human diseases. For example, angiogenesis-dependent diseases such as wet age-related macular degeneration and infantile hemangioma are more common in light-skinned individuals of mixed European descent than in African-Americans. Here we found that melanocytes from light-skinned humans and albino mice secrete high levels of fibromodulin (FMOD), which we determined to be a potent angiogenic factor. FMOD treatment stimulated angiogenesis in numerous in vivo systems, including laser-induced choroidal neovascularization, growth factor–induced corneal neovascularization, wound healing, and Matrigel plug assays. Additionally, FMOD enhanced vascular sprouting during normal retinal development. Deletion of Fmod in albino mice resulted in a marked reduction in the amount of neovascularization induced by retinal vein occlusion, corneal growth factor pellets, and Matrigel plugs. Our data implicate the melanocyte-secreted factor FMOD as a key regulator of angiogenesis and suggest an underlying mechanism for epidemiological differences between light-skinned individuals of mixed European descent and African-Americans. Furthermore, inhibition of FMOD in humans has potential as a therapeutic strategy for treating angiogenesis-dependent diseases.

Authors

Irit Adini, Kaustabh Ghosh, Avner Adini, Zai-Long Chi, Takeru Yoshimura, Ofra Benny, Kip M. Connor, Michael S. Rogers, Lauren Bazinet, Amy E. Birsner, Diane R. Bielenberg, Robert J. D’Amato

×

Figure 1

Effect of pigmented and nonpigmented melanocytes on angiogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Effect of pigmented and nonpigmented melanocytes on angiogenesis.
(A) Co...
(A) Corneal neovascular response in different inbred mouse strains induced by corneal implantation of FGF2 pellets (P) in C57-albino mice (left) with hyphema formation (H) and C57BL mice (right). The experiment included 10 eyes per group. (B) Iris neovascularization visualized with FITC–BS-1 lectin. Scale bars: 500 μm. The experiment included 10 eyes per group. (C) Quantification of iris vessel density of C57-albino versus C57BL. Experiment included 10 eyes per group. (D) Normal skin vessel density in C57-albino and C57BL mice labeled with CD31 antibody. Scale bar: 20 μm. (E) Angiogenesis during wound healing in ear skin. Blood vessels were perfused with FITC-conjugated BS-1 lectin (green) and photographed. Scale bars: 10 μm. The experiment included 5 wounds per group. (F) Analysis of microvessel density in albino ear skin. (G) Migration of HMVECs to CM from albino (CM-NP) and pigmented (CM-P) melanocytes. (H) Migration of HMVECs to CM from pigmented melanocytes grown in the presence and absence of tyrosine. (I) Migration of HMVECs to CM from human melanocytes (mixed European descent and African-American) through Transwells. (J) HMVEC proliferation in response to CM from nonpigmented or pigmented melanocytes for 24 hours; analysis by WST-1 at 450 O.D. (K) HMVECs incubated with CM from human melanocytes (mixed European descent and African-American) for 24 hours, followed by proliferation analysis with WST-1 at 450 O.D. All experiments were repeated at least 3 times. *P < 0.01; **P < 0.001; ***P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts